Continued Investment in R&D Funding and Uncertainty over Recovery
First written in FY2016. 9 of 36 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2019: 6 of 25 companies on the "Worse" side.
1 other company's latest entry also says "Other".
- FY2026Increase in annual R&D expensesAnnual report
「The total amount of research and development expenses incurred by the Company during the fiscal year was ¥62 million.」
Annual research and development expenses were ¥62 million, up from ¥52 million in the previous fiscal year. Continued investment in research and development is expanding. - 2026-05-15OtherEarnings
「Research and development expenses 52,577 62,385」
Research and development expenses increased from ¥52.577 million in the previous fiscal year to ¥62.385 million, indicating greater investment in R&D. - FY2026-H1Increase in interim R&D expensesAnnual report
「The amount of research and development activities during the interim accounting period was ¥30 million.」
Research and development expenses for the interim period were ¥30 million, up from approximately ¥26 million in the same period of the previous year. While continued investment in research and development is expanding, there is no new disclosure regarding the previously identified uncertainty over recovering the investment in development results. - FY2025Slight decrease in annual research and development expensesAnnual report
「The total amount of research and development expenses incurred by the Company during the fiscal year was ¥52 million.」
Annual research and development expenses were ¥52 million, slightly down from ¥53 million in the previous fiscal year. Continued investment in research and development is ongoing. - FY2025-H1Slight increase in interim research and development expensesAnnual report
「The amount of research and development activities during the interim accounting period was ¥26 million.」
Research and development expenses for the interim period were ¥26 million, broadly flat but slightly down from ¥26.361 million in the same period of the previous year. Continued investment in research and development is ongoing. - FY2024Increase in annual R&D expensesAnnual report
「The total amount of research and development expenses incurred by the Company during the fiscal year was ¥53 million.」
Annual research and development expenses were ¥53 million, up from ¥41 million in the previous fiscal year. While continued investment in research and development is expanding, uncertainty remains regarding the contribution of products under development to results. - FY2024-Q3Increase in research and development expenses in the third quarterAnnual report
「The amount of research and development activities during the cumulative third quarter was ¥38 million.」
Research and development expenses for the cumulative third quarter were ¥38 million, up from ¥30 million in the same period of the previous year and ¥26 million in the previous cumulative quarter. Continued investment in research and development is expanding. - FY2024-Q2Increase in second-quarter R&D expensesAnnual report
「The amount of research and development activities during the cumulative second quarter was ¥26 million.」
Research and development expenses for the cumulative second quarter were ¥26 million, up from ¥20 million in the same period of the previous year. It is stated that there were no material changes in the status of the research and development activities. - FY2024-Q1Increase in research and development expenses in the first quarterAnnual report
「The amount of research and development activities during the cumulative first quarter was ¥13 million. There were no material changes in the status of the Company's research and development activities during the cumulative first quarter.」
Research and development expenses for the cumulative first quarter were ¥13 million, up from ¥10 million in the same period of the previous year. It is stated that there were no material changes in the status of the research and development activities. - FY2023Increase in annual R&D expensesAnnual report
「The Company's total R&D expenses for the current fiscal year were ¥41 million.」
Annual research and development expenses were ¥41 million, up from ¥27 million in the previous fiscal year. Investment in research and development is expanding. - FY2023-Q3Increase in research and development expenses in the third quarterAnnual report
「The amount of research and development activities during the cumulative third quarter was ¥31 million.」
Research and development expenses for the cumulative third quarter were ¥31 million, up from ¥18 million in the same period of the previous year. Investment in research and development is continuing. - FY2023-Q2Increase in second-quarter R&D expensesAnnual report
「The amount of research and development activities during the cumulative second quarter was ¥20 million.」
Research and development expenses for the cumulative second quarter were ¥20 million, up from approximately ¥9.9 million in the same period of the previous year. Investment in research and development is continuing. - FY2023-Q1Increase in research and development expenses in the first quarterAnnual report
「The amount of research and development activities during the cumulative first quarter was ¥10 million. There were no material changes in the status of the Company's research and development activities during the cumulative first quarter.」
Research and development expenses for the cumulative first quarter were ¥10 million, up from ¥8 million in the same period of the previous year. It is stated that there were no material changes in the status of the research and development activities themselves. - FY2022Annual R&D expenses decreasedAnnual report
「The total amount of research and development expenses incurred by the Company during the fiscal year was ¥27 million.」
Annual research and development expenses were ¥27 million, down from ¥45 million in the previous fiscal year. Research and development activities are continuing. - FY2022-Q3Decline in third-quarter R&D expensesAnnual report
「The amount of research and development activities during the cumulative third quarter was ¥18 million. There were no material changes in the status of the Company's research and development activities during the cumulative third quarter.」
Research and development expenses for the cumulative third quarter were ¥18 million, down from ¥30 million in the same period of the previous year. It is stated that there were no material changes in the status of the research and development activities themselves. - FY2022-Q2Decline in second-quarter R&D expensesAnnual report
「The amount of research and development activities during the cumulative second quarter was ¥9 million. There were no material changes in the status of the Company's research and development activities during the cumulative second quarter.」
Research and development expenses for the cumulative second quarter were ¥9 million, down from ¥20 million in the same period of the previous year. It is stated that there were no material changes in the status of the research and development activities themselves. - FY2022-Q1Decrease in research and development expenses in the first quarterAnnual report
「The amount of research and development activities during the cumulative first quarter was ¥4 million. There were no material changes in the status of the Company's research and development activities during the cumulative first quarter.」
Research and development expenses for the cumulative first quarter were ¥4 million, down from ¥8 million in the same period of the previous year. It is stated that there were no material changes in the status of research and development activities. - FY2021Increase in annual R&D expensesAnnual report
「The total amount of research and development expenses incurred by the Company during the fiscal year was ¥45 million.」
Research and development expenses increased to ¥45 million from ¥35 million in the previous fiscal year, confirming continued investment in research and development. - FY2021-Q3RestatedAnnual report
「The amount spent on R&D activities during the first nine months of the current fiscal year was ¥30 million. There were no material changes in the status of the Company's R&D activities during the first nine months of the current fiscal year.」
R&D expenses totaled ¥30 million for the first nine months, reaffirming continued investment along with the absence of material changes in R&D activities. - FY2021-Q2Increase in second-quarter R&D expensesAnnual report
「The amount spent on R&D activities during the first six months of the current fiscal year was ¥20 million. There were no material changes in the status of the Company's R&D activities during the first six months of the current fiscal year.」
R&D expenses for the first six months totaled ¥20 million, up from ¥19 million in the same period of the previous fiscal year. The Company stated that there were no material changes in its R&D activities. - FY2021-Q1RestatedAnnual report
「The amount spent on R&D activities during the first three months of the current fiscal year was ¥8 million. There were no material changes in the status of the Company's R&D activities during the first three months of the current fiscal year.」
R&D expenses totaled ¥8 million for the first three months, reaffirming continued investment along with the absence of material changes in R&D activities. - FY2020Increase in annual R&D expensesAnnual report
「The Company's total R&D expenses for the current fiscal year were ¥35 million.」
Annual R&D expenses were ¥35 million, up from ¥32 million in the previous fiscal year. While continued R&D investment has been confirmed, uncertainty over recovering the investment remains. - FY2020-Q3Decline in third-quarter R&D expensesAnnual report
「The amount spent on R&D activities during the first nine months of the current fiscal year was ¥26 million.」
R&D expenses totaled ¥26 million, down from ¥30 million in the same period of the previous fiscal year, but spending on R&D activities is continuing. - FY2020-Q2Decline in second-quarter R&D expensesAnnual report
「The amount spent on R&D activities during the first six months of the current fiscal year was ¥16 million.」
R&D expenses declined to ¥16 million from ¥19 million in the same period of the previous fiscal year, but spending on R&D activities itself is continuing. - FY2019Decrease in R&D ExpensesAnnual report
「The Company's total R&D expenses for the current fiscal year were ¥32 million.」
R&D expenses totaled ¥32 million, down from ¥41 million in the previous fiscal year, but spending on R&D activities is continuing. - FY2019-Q3Decline in third-quarter R&D expensesAnnual report
「The amount spent on R&D activities during the first nine months of the current fiscal year was ¥25 million.」
R&D expenses totaled ¥25 million for the first nine months, down from ¥30 million in the same period of the previous fiscal year. Spending on R&D activities itself is continuing. - FY2019-Q2RestatedAnnual report
「The amount spent on R&D activities during the first six months of the current fiscal year was ¥15 million.」
Spending on R&D activities was recorded at ¥15 million for the first six months, reaffirming continued investment. - FY2019-Q1Quarterly R&D expenses declineAnnual report
「The amount spent on R&D activities during the first three months of the current fiscal year was ¥8 million.」
First-quarter R&D expenses were ¥8 million, down from ¥9 million in the same period of the previous fiscal year. Spending on R&D activities itself is continuing. - FY2018Decrease in R&D ExpensesAnnual report
「The Company's total R&D expenses for the current fiscal year were ¥41 million.」
Annual R&D expenses were ¥41 million, down from ¥55 million in the previous fiscal year. Continued R&D investment remains ongoing. - FY2018-Q3RestatedAnnual report
「The amount spent on R&D activities during the first nine months of the current fiscal year was ¥30 million.」
Continued spending on R&D activities is shown by cumulative nine-month spending of ¥30 million. - FY2018-Q2RestatedAnnual report
「The amount spent on R&D activities during the first six months of the current fiscal year was ¥19 million.」
Continued spending on R&D activities is shown by cumulative first-half spending of ¥19 million. - FY2018-Q1RestatedAnnual report
「The amount spent on R&D activities during the first three months of the current fiscal year was ¥9 million.」
R&D expenses for the first quarter totaled ¥9 million, indicating continued spending on R&D activities. - FY2017RestatedAnnual report
「The Company's total R&D expenses for the current fiscal year were ¥55 million.」
Continued R&D investment is shown by annual spending of ¥55 million. - FY2017-Q3RestatedAnnual report
「The amount spent on R&D activities during the first nine months of the current fiscal year was ¥40 million.」
Continued R&D investment is shown by actual spending of ¥40 million. - FY2017-Q2RestatedAnnual report
「The amount spent on R&D activities during the first six months of the current fiscal year was ¥27 million.」
Continued R&D investment is shown by the actual amount spent. - FY2016First statedAnnual report
「Total annual R&D expenses were ¥59 million for the fiscal year ended March 2012, ¥57 million for the fiscal year ended March 2013, ¥60 million for the fiscal year ended March 2014, ¥62 million for the fiscal year ended March 2015, and ¥61 million for the fiscal year ended March 2016.」
Although the Company continues to invest in R&D, it states that there is no assurance that it will be able to maintain such investment steadily in the future or that sales will increase.